Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it
Briefly

Aging, like inflation, is unavoidable and reduces life quality over time. While healthy living helps, it won't stop aging; advanced studies are needed to develop longevity solutions.
Emerging longevity biotechnology aims to combat the aging process directly. Although initially reserved for the wealthy, treatments historically become more accessible, improving lives beyond just diet and exercise.
The fundamentals of healthy living—diet, exercise, sleep, meditation—are widely known but underutilized. More advanced lifestyle studies at significant events like ARDD are crucial for real progress.
Longevity biotech has its roots in the 1990s, with early ventures in telomerase activation and stem cells. Initial excitement faded as ventures failed or changed focus.
Read at Fortune
[
|
]